Amdocs (DOX) Competitors

Leidos (NYSE:LDOS) and Amdocs (NASDAQ:DOX) are both aerospace companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, community ranking, media sentiment, valuation and risk.

Which has more risk and volatility, LDOS or DOX?

Leidos has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500.

Does the MarketBeat Community prefer LDOS or DOX?

Amdocs received 5 more outperform votes than Leidos when rated by MarketBeat users. Likewise, 72.78% of users gave Amdocs an outperform vote while only 64.47% of users gave Leidos an outperform vote.

Company	Underperform	Outperform
Leidos	Outperform Votes 666 64.47%	Underperform Votes 367 35.53%
Amdocs	Outperform Votes 671 72.78%	Underperform Votes 251 27.22%

Do insiders and institutionals believe in LDOS or DOX?

76.1% of Leidos shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 1.0% of Leidos shares are held by insiders. Comparatively, 15.4% of Amdocs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is LDOS or DOX a better dividend stock?

Leidos pays an annual dividend of $1.60 per share and has a dividend yield of 1.0%. Amdocs pays an annual dividend of $1.92 per share and has a dividend yield of 2.2%. Leidos pays out 18.2% of its earnings in the form of a dividend. Amdocs pays out 45.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 13 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Which has preferable earnings and valuation, LDOS or DOX?

Amdocs has lower revenue, but higher earnings than Leidos. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Leidos	$15.44B	1.39	$199M	$8.78	18.29
Amdocs	$5.00B	1.93	$493.20M	$4.24	20.21

Is LDOS or DOX more profitable?

Amdocs has a net margin of 9.85% compared to Leidos' net margin of 7.37%. Leidos' return on equity of 30.31% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Leidos	7.37%	30.31%	10.39%
Amdocs	9.85%	18.69%	10.37%

Do analysts rate LDOS or DOX?

Leidos presently has a consensus price target of $179.07, indicating a potential upside of 11.50%. Amdocs has a consensus price target of $101.20, indicating a potential upside of 18.09%. Given Amdocs' stronger consensus rating and higher possible upside, analysts clearly believe Amdocs is more favorable than Leidos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Leidos	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64
Amdocs	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Does the media refer more to LDOS or DOX?

In the previous week, Leidos had 7 more articles in the media than Amdocs. MarketBeat recorded 11 mentions for Leidos and 4 mentions for Amdocs. Leidos' average media sentiment score of 0.84 beat Amdocs' score of 0.63 indicating that Leidos is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Leidos	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Amdocs beats Leidos on 13 of the 21 factors compared between the two stocks.